Everest Organics Shares Gain by 5% after Successful USFDA inspection
Shital Jibhe / 06 Jun 2017
Everest Organics was locked in its upper circuit of Rs 108.15 per share, higher by 5% intraday on Tuesday after a successful check of its facility by the United States Food and Drug Administration (USFDA).
Everest Organics was locked in its upper circuit of Rs 108.15 per share, higher by 5% intraday on Tuesday after a successful check of its facility by the United States Food and Drug Administration (USFDA).
Everest Organics Limited is an innovative research-driven, global pharmaceutical company that develops, manufactures and markets a broad range of APls / bulks drugs intermediates.
However, the stock got unlocked from its upper circuit in the afternoon hours and was trading flat at Rs 103 per share as of 1415 hours.
The manufacturing facility at Aroor village was inspected by the USFDA between February 27 and March 3,
Everest Organics Limited globally exports to more than 20 countries.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.